-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Arrowhead Pharma (ARWR)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Arrowhead Pharma (ARWR)
-
-
-
-
-
-
-
Arrowhead receives Australia approval for rare disease drug REDEMPLO
-
-
-
-
-
-
-
RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
-
-
-
-
-
-
-
'Arrowhead Pharma (ARWR) Raises $930 Million to Launch Redemplo'; PT Raised at Piper Sandler
-
-
-
-
-
-
-
Arrowhead Pharmaceuticals reports interim obesity drug trial results
-
-
-
-
-
-
-
Piper Sandler Names Arrowhead Pharma (ARWR) 'A Top Pick for 2026', Lifts Stock PT
-
480,936 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


